학술논문
The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab
Document Type
Article
Author
Source
In JTO Clinical and Research Reports December 2023 4(12)
Subject
Language
ISSN
2666-3643